Download PDF
Semin Thromb Hemost 2015; 41(06): 572-581
DOI: 10.1055/s-0035-1556589
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Platelets in Inflammatory Disorders: A Pathophysiological and Clinical Perspective

Jecko Thachil
1   Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
15 August 2015 (online)

    Permissions and Reprints

Abstract

Platelets are well recognized as a key cell component of the hemostatic system. Recently, several additional functions have been discovered for these blood cells but most importantly in the process of inflammation. Numerous research groups have demonstrated crucial roles for platelets in the pathogenesis of varied clinical conditions where inflammation is important. Alterations in both platelet number and function have been observed with these different conditions. The relevance of these findings is their therapeutic implications through simple antiplatelet therapy to more complex, as yet clinically untrialed options, like interfering with platelet–leukocyte or platelet–endothelial interaction. This review focuses on how platelets are relevant in inflammatory conditions with an impetus on the clinical aspects.

Keywords

inflammation - platelets - thrombosis
 

  • References

  • 1 Opal SM, Esmon CT. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003; 7 (1) 23-38
    CrossrefPubMedGoogle Scholar
  • 2 Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately?. Blood 2009; 114 (12) 2367-2374
    CrossrefPubMedGoogle Scholar
  • 3 Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007; 127 (3) 514-525
    CrossrefPubMedGoogle Scholar
  • 4 Dahlbäck B. Coagulation and inflammation—close allies in health and disease. Semin Immunopathol 2012; 34 (1) 1-3
    CrossrefPubMedGoogle Scholar
  • 5 Jin RC, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation 2005; 12 (3) 247-258
    CrossrefPubMedGoogle Scholar
  • 6 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115 (12) 3378-3384
    CrossrefPubMedGoogle Scholar
  • 7 Gawaz M, Brand K, Dickfeld T , et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000; 148 (1) 75-85
    CrossrefPubMedGoogle Scholar
  • 8 Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 2009; 54 (8) 669-677
    CrossrefPubMedGoogle Scholar
  • 9 Pamukcu B, Lip GY, Snezhitskiy V, Shantsila E. The CD40-CD40L system in cardiovascular disease. Ann Med 2011; 43 (5) 331-340
    CrossrefPubMedGoogle Scholar
  • 10 Ho-Tin-Noé B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost 2011; 9 (Suppl. 01) 56-65
    CrossrefPubMedGoogle Scholar
  • 11 Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?. Cardiovasc Res 1997; 34 (2) 255-265
    CrossrefPubMedGoogle Scholar
  • 12 Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD. von Willebrand factor is an acute phase reactant in man. Thromb Res 1989; 53 (4) 387-394
    CrossrefPubMedGoogle Scholar
  • 13 Thachil J. The difficult distinction between antiphospholipid syndrome and thrombotic thrombocytopenic purpura. Br J Haematol 2010; 149 (2) 294-295
    CrossrefPubMedGoogle Scholar
  • 14 Thachil J. Lessons from acute pancreatitis-induced thrombotic thrombocytopenic purpura. Eur J Intern Med 2009; 20 (8) 739-743
    CrossrefPubMedGoogle Scholar
  • 15 van Mourik JA, Boertjes R, Huisveld IA , et al. von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999; 94 (1) 179-185
    PubMedGoogle Scholar
  • 16 Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med 2008; 205 (9) 2065-2074
    CrossrefPubMedGoogle Scholar
  • 17 Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 1999; 81 (1) 1-7
    PubMedGoogle Scholar
  • 18 Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 2007; 21 (2) 99-111
    CrossrefPubMedGoogle Scholar
  • 19 van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009; 85 (2) 195-204
    CrossrefPubMedGoogle Scholar
  • 20 Ghasemzadeh M, Hosseini E. Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state. Thromb Res 2013; 131 (3) 191-197
    CrossrefPubMedGoogle Scholar
  • 21 von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007; 97 (5) 704-713
    PubMedGoogle Scholar
  • 22 Li N. Platelet-lymphocyte cross-talk. J Leukoc Biol 2008; 83 (5) 1069-1078
    CrossrefPubMedGoogle Scholar
  • 23 Corken A, Russell S, Dent J, Post SR, Ware J. Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arterioscler Thromb Vasc Biol 2014; 34 (5) 996-1001
    CrossrefPubMedGoogle Scholar
  • 24 Polley MJ, Nachman R. The human complement system in thrombin-mediated platelet function. J Exp Med 1978; 147 (6) 1713-1726
    CrossrefPubMedGoogle Scholar
  • 25 Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol 2010; 47 (13) 2170-2175
    CrossrefPubMedGoogle Scholar
  • 26 Del Conde I, Crúz MA, Zhang H, López JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005; 201 (6) 871-879
    CrossrefPubMedGoogle Scholar
  • 27 Hamad OA, Bäck J, Nilsson PH, Nilsson B, Ekdahl KN. Platelets, complement, and contact activation: partners in inflammation and thrombosis. Adv Exp Med Biol 2012; 946: 185-205
    PubMedGoogle Scholar
  • 28 Karshovska E, Weber C, von Hundelshausen P. Platelet chemokines in health and disease. Thromb Haemost 2013; 110 (5) 894-902
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Kaplan ZS, Jackson SP. The role of platelets in atherothrombosis. Hematology (Am Soc Hematol Educ Program) 2011; 2011 (11) 51-61
    CrossrefPubMedGoogle Scholar
  • 30 Smid J, Braun-Dullaeus R, Gawaz M, Langer HF. Platelet interactions as therapeutic targets for prevention of atherothrombosis. Future Cardiol 2009; 5 (3) 285-296
    CrossrefPubMedGoogle Scholar
  • 31 Zucker-Franklin D, Philipp CS. Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol 2000; 157 (1) 69-74
    CrossrefPubMedGoogle Scholar
  • 32 Trowbridge EA, Martin JF, Slater DN. Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation. Thromb Res 1982; 28 (4) 461-475
    CrossrefPubMedGoogle Scholar
  • 33 Dickinson CJ, Martin JF. Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet 1987; 2 (8573) 1434-1435
    PubMedGoogle Scholar
  • 34 Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol 2009; 40 (2) 123-134
    CrossrefPubMedGoogle Scholar
  • 35 Schneider RC, Zapol WM, Carvalho AC. Platelet consumption and sequestration in severe acute respiratory failure. Am Rev Respir Dis 1980; 122 (3) 445-451
    PubMedGoogle Scholar
  • 36 Bone RC, Francis PB, Pierce AK. Intravascular coagulation associated with the adult respiratory distress syndrome. Am J Med 1976; 61 (5) 585-589
    CrossrefPubMedGoogle Scholar
  • 37 Peng X, Hassoun PM, Sammani S , et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004; 169 (11) 1245-1251
    CrossrefPubMedGoogle Scholar
  • 38 Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006; 116 (12) 3211-3219
    CrossrefPubMedGoogle Scholar
  • 39 O'Sullivan BP, Michelson AD. The inflammatory role of platelets in cystic fibrosis. Am J Respir Crit Care Med 2006; 173 (5) 483-490
    CrossrefPubMedGoogle Scholar
  • 40 Gross S, Luckey C. The oxygen tension-platelet relationship in cystic fibrosis. Am Rev Respir Dis 1969; 100 (4) 513-517
    PubMedGoogle Scholar
  • 41 O'Sullivan BP, Linden MD, Frelinger III AL , et al. Platelet activation in cystic fibrosis. Blood 2005; 105 (12) 4635-4641
    CrossrefPubMedGoogle Scholar
  • 42 Abraham EH, Sterling KM, Kim RJ , et al. Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol Dis 2001; 27 (1) 165-180
    CrossrefPubMedGoogle Scholar
  • 43 Ciabattoni G, Davì G, Collura M , et al. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med 2000; 162 (4, Pt 1): 1195-1201
    CrossrefPubMedGoogle Scholar
  • 44 Page C, Pitchford S. Platelets and allergic inflammation. Clin Exp Allergy 2014; 44 (7) 901-913
    CrossrefPubMedGoogle Scholar
  • 45 Dürk T, Duerschmied D, Müller T , et al. Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation. Am J Respir Crit Care Med 2013; 187 (5) 476-485
    CrossrefPubMedGoogle Scholar
  • 46 Yoshida A, Ohba M, Wu X, Sasano T, Nakamura M, Endo Y. Accumulation of platelets in the lung and liver and their degranulation following antigen-challenge in sensitized mice. Br J Pharmacol 2002; 137 (2) 146-152
    CrossrefPubMedGoogle Scholar
  • 47 Svensson Holm AC, Bengtsson T, Grenegård M, Lindström EG. Platelet membranes induce airway smooth muscle cell proliferation. Platelets 2011; 22 (1) 45-55
    PubMedGoogle Scholar
  • 48 Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet 2013; 382 (9896) 984-994
    CrossrefPubMedGoogle Scholar
  • 49 Caudrillier A, Kessenbrock K, Gilliss BM , et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122 (7) 2661-2671
    CrossrefPubMedGoogle Scholar
  • 50 Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009; 119 (11) 3450-3461
    PubMedGoogle Scholar
  • 51 Serebruany VL. Viewpoint: reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel. Thromb Haemost 2012; 108 (6) 1024-1027
    Article in Thieme ConnectPubMedGoogle Scholar
  • 52 Maclay JD, McAllister DA, Johnston S , et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011; 66 (9) 769-774
    CrossrefPubMedGoogle Scholar
  • 53 Harrison MT, Short P, Williamson PA, Singanayagam A, Chalmers JD, Schembri S. Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for anti-platelet therapy?. Thorax Published Online First 2014; 69 (7) 609-615
    PubMedGoogle Scholar
  • 54 Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 2011; 31 (2) 153-164
    CrossrefPubMedGoogle Scholar
  • 55 Pamuk GE, Vural O, Turgut B, Demir M, Pamuk ON, Cakir N. Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis?. Platelets 2008; 19 (2) 146-154
    CrossrefPubMedGoogle Scholar
  • 56 Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002; 46 (6) 1498-1503
    CrossrefPubMedGoogle Scholar
  • 57 Ertenli I, Kiraz S, Arici M , et al. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol 1998; 25 (6) 1054-1058
    PubMedGoogle Scholar
  • 58 Mac Mullan PA, Peace AJ, Madigan AM, Tedesco AF, Kenny D, McCarthy GM. Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target. Rheumatology (Oxford) 2010; 49 (2) 240-245
    CrossrefPubMedGoogle Scholar
  • 59 Boilard E, Nigrovic PA, Larabee K , et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327 (5965) 580-583
    CrossrefPubMedGoogle Scholar
  • 60 Cloutier N, Paré A, Farndale RW , et al. Platelets can enhance vascular permeability. Blood 2012; 120 (6) 1334-1343
    CrossrefPubMedGoogle Scholar
  • 61 Postlethwaite AE, Chiang TM. Platelet contributions to the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2007; 19 (6) 574-579
    CrossrefPubMedGoogle Scholar
  • 62 Dees C, Akhmetshina A, Zerr P , et al. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 2011; 208 (5) 961-972
    CrossrefPubMedGoogle Scholar
  • 63 Pauling JD, O'Donnell VB, Mchugh NJ. The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis. Platelets 2013; 24 (7) 503-515
    CrossrefPubMedGoogle Scholar
  • 64 Maugeri N, Franchini S, Campana L , et al. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 2012; 45 (8) 584-587
    CrossrefPubMedGoogle Scholar
  • 65 Ziakas PD, Giannouli S, Zintzaras E, Tzioufas AG, Voulgarelis M. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis 2005; 64 (9) 1366-1369
    CrossrefPubMedGoogle Scholar
  • 66 Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets 2010; 21 (5) 380-385
    CrossrefPubMedGoogle Scholar
  • 67 Garcia-Romo GS, Caielli S, Vega B , et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011; 3 (73) 73ra20
    PubMedGoogle Scholar
  • 68 Clark SR, Ma AC, Tavener SA , et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13 (4) 463-469
    CrossrefPubMedGoogle Scholar
  • 69 Fuchs TA, Brill A, Duerschmied D , et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010; 107 (36) 15880-15885
    CrossrefPubMedGoogle Scholar
  • 70 Lood C, Eriksson S, Gullstrand B , et al. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus—a possible link to venous thrombosis?. Lupus 2012; 21 (13) 1423-1432
    CrossrefPubMedGoogle Scholar
  • 71 Delmas Y, Viallard JF, Solanilla A , et al. Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. Kidney Int 2005; 68 (5) 2068-2078
    CrossrefPubMedGoogle Scholar
  • 72 Tanaka T, Kuroiwa T, Ikeuchi H , et al. Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury. J Am Soc Nephrol 2002; 13 (10) 2488-2496
    CrossrefPubMedGoogle Scholar
  • 73 Voudoukis E, Karmiris K, Koutroubakis IE. Multipotent role of platelets in inflammatory bowel diseases: a clinical approach. World J Gastroenterol 2014; 20 (12) 3180-3190
    CrossrefPubMedGoogle Scholar
  • 74 Morowitz DA, Allen LW, Kirsner JB. Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med 1968; 68 (5) 1013-1021
    CrossrefPubMedGoogle Scholar
  • 75 Thachil J. Extreme thrombocytosis—an unusual presentation of inflammatory bowel disease. Intern Med 2008; 47 (13) 1255-1257
    CrossrefPubMedGoogle Scholar
  • 76 Kulnigg-Dabsch S, Evstatiev R, Dejaco C, Gasche C. Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLoS ONE 2012; 7 (4) e34520
    CrossrefPubMedGoogle Scholar
  • 77 Kulnigg-Dabsch S, Schmid W, Howaldt S , et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflamm Bowel Dis 2013; 19 (8) 1609-1616
    CrossrefPubMedGoogle Scholar
  • 78 Danese S, de la Motte C, Sturm A , et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124 (5) 1249-1264
    CrossrefPubMedGoogle Scholar
  • 79 Danese S, Scaldaferri F, Vetrano S , et al. Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut 2007; 56 (9) 1248-1256
    CrossrefPubMedGoogle Scholar
  • 80 Irving PM, Macey MG, Shah U, Webb L, Langmead L, Rampton DS. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis 2004; 10 (4) 361-372
    CrossrefPubMedGoogle Scholar
  • 81 Andoh A, Tsujikawa T, Hata K , et al. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol 2005; 100 (9) 2042-2048
    CrossrefPubMedGoogle Scholar
  • 82 Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A. Evidence of platelet activation in multiple sclerosis. J Neuroinflammation 2008; 5: 27
    CrossrefPubMedGoogle Scholar
  • 83 Thornton P, McColl BW, Greenhalgh A, Denes A, Allan SM, Rothwell NJ. Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood 2010; 115 (17) 3632-3639
    CrossrefPubMedGoogle Scholar
  • 84 Bush AI, Martins RN, Rumble B , et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 1990; 265 (26) 15977-15983
    PubMedGoogle Scholar
  • 85 Zhang W, Huang W, Jing F. Contribution of blood platelets to vascular pathology in Alzheimer's disease. J Blood Med 2013; 4: 141-147
    PubMedGoogle Scholar
  • 86 Ciabattoni G, Porreca E, Di Febbo C , et al. Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging 2007; 28 (3) 336-342
    CrossrefPubMedGoogle Scholar
  • 87 Prodan CI, Ross ED, Vincent AS, Dale GL. Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol 2007; 254 (4) 548-549
    CrossrefPubMedGoogle Scholar
  • 88 Bentham P, Gray R, Sellwood E, Hills R, Crome P, Raftery J ; AD2000 Collaborative Group. Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial. Lancet Neurol 2008; 7 (1) 41-49
    CrossrefPubMedGoogle Scholar